Paragon 28, Inc. (NYSE:FNA – Get Free Report) major shareholder Mvm Partners, Llc sold 72,133 shares of the company’s stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $10.16, for a total value of $732,871.28. Following the sale, the insider now directly owns 10,559,065 shares of the company’s stock, valued at approximately $107,280,100.40. This represents a 0.68 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
Mvm Partners, Llc also recently made the following trade(s):
- On Monday, November 25th, Mvm Partners, Llc sold 10,835 shares of Paragon 28 stock. The shares were sold at an average price of $10.09, for a total value of $109,325.15.
- On Wednesday, November 20th, Mvm Partners, Llc sold 147,581 shares of Paragon 28 stock. The shares were sold at an average price of $10.28, for a total value of $1,517,132.68.
Paragon 28 Stock Performance
NYSE FNA opened at $9.99 on Thursday. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79. The business’s 50 day moving average is $6.89 and its two-hundred day moving average is $7.26. Paragon 28, Inc. has a 12-month low of $4.65 and a 12-month high of $14.79. The stock has a market capitalization of $836.36 million, a price-to-earnings ratio of -13.50 and a beta of 1.01.
Analyst Ratings Changes
Several research firms have commented on FNA. Canaccord Genuity Group reduced their price objective on Paragon 28 from $17.00 to $15.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Needham & Company LLC boosted their target price on Paragon 28 from $11.00 to $13.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Finally, Piper Sandler reiterated an “overweight” rating and set a $12.00 target price (down previously from $15.00) on shares of Paragon 28 in a research report on Friday, August 9th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Paragon 28 presently has an average rating of “Buy” and a consensus price target of $15.60.
Check Out Our Latest Report on Paragon 28
Institutional Investors Weigh In On Paragon 28
A number of institutional investors and hedge funds have recently modified their holdings of the company. First Light Asset Management LLC grew its holdings in shares of Paragon 28 by 115.0% in the 2nd quarter. First Light Asset Management LLC now owns 8,174,832 shares of the company’s stock worth $55,916,000 after acquiring an additional 4,371,864 shares during the period. Vanguard Group Inc. grew its holdings in shares of Paragon 28 by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 2,106,217 shares of the company’s stock worth $26,012,000 after acquiring an additional 55,851 shares during the period. State Street Corp grew its holdings in Paragon 28 by 2.6% during the 3rd quarter. State Street Corp now owns 1,563,331 shares of the company’s stock valued at $10,443,000 after buying an additional 39,075 shares during the last quarter. Janus Henderson Group PLC grew its holdings in Paragon 28 by 29.5% during the 1st quarter. Janus Henderson Group PLC now owns 1,199,819 shares of the company’s stock valued at $14,818,000 after buying an additional 273,077 shares during the last quarter. Finally, Thrivent Financial for Lutherans grew its holdings in Paragon 28 by 15.4% during the 2nd quarter. Thrivent Financial for Lutherans now owns 1,021,188 shares of the company’s stock valued at $6,986,000 after buying an additional 135,911 shares during the last quarter. Institutional investors and hedge funds own 63.57% of the company’s stock.
Paragon 28 Company Profile
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Featured Stories
- Five stocks we like better than Paragon 28
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Top Stocks Investing in 5G Technology
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Basic Materials Stocks Investing
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.